CME Group Inc.
CME
Positions held
Your positionsCME isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-07.
- CME Group Inc. operates in a competitive landscape with a strong market position, benefiting from its established reputation and diverse product offerings in financial data and stock exchanges.
- In 2026-Q1, CME reported a revenue of $1.88 billion, with an operating margin of 69.7%, showcasing strong profitability.
- The company has a profit margin of 63.4% and a return on equity (ROE) of 15.8%, indicating efficient management and strong financial health.
- The financial services industry is currently facing regulatory pressures that could impact trading volumes and profitability for exchanges like CME.
- CME's revenue decreased by 9% in the latest quarter compared to the prior quarter, dropping from $1.9 billion to $1.7 billion.
- The operating margin has compressed to 64.9%, down from 69.7% in the previous quarter, indicating potential challenges in maintaining profitability.
Fundamentals
| Market cap | $99.40B | Enterprise value | $100.99B | Trailing P/E | 23.45 | Forward P/E | 21.34 |
| PEG | 4.70 | Price / book | 3.74 | Beta | 0.27 | Dividend yield | 1.88% |
| Revenue growth | 0.8% | Earnings growth | 2.5% | Gross margin | 100.0% | Operating margin | 65.0% |
| Profit margin | 63.4% | ROE | 15.8% | ROA | 1.5% | Debt / equity | 0.15 |
| Current ratio | 1.02 | Free cash flow | $2.91B | Analyst recommendation | buy | Mean target | $288.63 |
| 52w high | $329.16 | 52w low | $218.31 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $1.7B | $1.9B | $1.6B | $1.5B | $1.7B | — |
| Op margin | 64.9% | 69.7% | 61.8% | 63.3% | 66.7% | — |
| Net income | $1.0B | $1.2B | $1.2B | $908M | $1.0B | — |
| Gross margin | 86.3% | 88.1% | 85.4% | 84.5% | 86.9% | — |
| Gross profit | $1.5B | $1.7B | $1.4B | $1.3B | $1.5B | — |
| Operating income | $1.1B | $1.3B | $1.0B | $973M | $1.1B | — |
- Revenue -9% vs prior quarter ($1.7B vs $1.9B).
- Gross margin 86.3% (was 88.1% prior quarter).
- Operating margin compressed to 64.9%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $6.5B | $6.1B | $5.6B | $5.0B | — |
| Op margin | 64.9% | 64.1% | 61.6% | 60.1% | — |
| Net income | $4.1B | $3.5B | $3.2B | $2.7B | — |
| Gross margin | 86.1% | 86.1% | 85.1% | 85.0% | — |
| Gross profit | $5.6B | $5.3B | $4.8B | $4.3B | — |
| Operating income | $4.2B | $3.9B | $3.4B | $3.0B | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-09 · Morgan Stanley Adjusts Price Target on CME Group to $337 From $330
2026-10-08 · CME to Launch Futures Contracts Tied to Baseball
2026-10-08 · Should S&P Global Stock Holders Look At Intercontinental Exchange Instead?
2026-10-08 · CME Group (CME) Adds Climate Linked Futures As International Volume Jumps 22%
2026-10-08 · Rothschild & Co Redburn Adjusts Price Target on CME to $330 From $317
2026-10-08 · CME Group Logs 22% Jump in Q3 International Average Daily Volume
2026-10-08 · CME Group's International Average Daily Volume Rises 22% to 9 Million Contracts in Q3 2026
2026-10-07 · Jefferies Adjusts CME Group Price Target to $328 From $286
2026-10-07 · Can ICE's Exchange Business Sustain Its Growth Momentum?
2026-10-07 · Barclays Adjusts Price Target on CME Group to $281 From $270
2026-10-07 · Marex Group Names John Pietrowicz as Chair
2026-10-07 · Marex announces changes to Group Board
Price (daily)
Full chart · RSI · MACD · patterns